Liposarcomas

https://doi.org/10.1016/j.hoc.2013.07.010Get rights and content

Section snippets

Key points

  • •

    Liposarcoma (LPS) is a heterogeneous disease with distinct subentities presenting with differential clinical behavior.

  • •

    From a clinical perspective, grading of liposarcomas is of greatest importance for decision making in localized tumors, as it greatly determines prognosis and aggressiveness of local treatment.

  • •

    Patients suspected of LPS should be managed by a multidisciplinary team with expertise in treating sarcomas.

  • •

    For the treatment of locally advanced liposarcomas, several neoadjuvant or

First page preview

First page preview
Click to open first page preview
View PDF

References (102)

  • F. Grosso et al.

    Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

    Lancet Oncol

    (2007)
  • W.T. Van der Graaf et al.

    Pazopanib for Metastatic Soft-Tissue Sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

    Lancet

    (2012)
  • A. Italiano et al.

    Advanced pleomorphic liposarcomas: clinical outcome and impact of chemotherapy

    Ann Oncol

    (2012)
  • D. Michael et al.

    The p53-Mdm2 module and the ubiquitin system

    Semin Cancer Biol

    (2003)
  • I. Ray-Coquard et al.

    Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study

    Lancet Oncol

    (2012)
  • S. Ortega et al.

    Cyclin D-dependent kinases, INK4 inhibitors and cancer

    Biochim Biophys Acta

    (2002)
  • T. Peng et al.

    An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors

    Lab Invest

    (2011)
  • T.M. Mack

    Sarcomas and other malignancies of soft tissue, retroperitoneum, peritoneum, pleura, heart, mediastinum, and spleen

    Cancer

    (1995)
  • S.M. Gadgeel et al.

    Patterns of care in a population-based sample of soft tissue sarcoma patients in the United States

    Cancer

    (2009)
  • A.M. Crago et al.

    Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma

    Curr Opin Oncol

    (2011)
  • L.G. Kindblom et al.

    Liposarcoma: a clinicopathologic, radiographic and prognostic study

    Acta Pathol Microbiol Scand Suppl

    (1975)
  • H.L. Evans

    Liposarcoma: a study of 55 cases with reassessment of its classification

    Am J Surg Pathol

    (1979)
  • C.D. Fletcher et al.

    WHO classification of tumours of soft tissue and bone

    (2013)
  • S.W. Weiss et al.

    Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites

    Am J Surg Pathol

    (1992)
  • S.E. Kilpatrick et al.

    The clinicopathologic spectrum of myxoid and round cell liposarcoma

    Cancer

    (1996)
  • W.H. Henricks et al.

    Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation

    Am J Surg Pathol

    (1997)
  • S. Gebhard et al.

    Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group

    Am J Surg Pathol

    (2002)
  • J.L. Hornick et al.

    Pleomorphic liposarcoma

    Am J Surg Pathol

    (2004)
  • R.J. Canter et al.

    Why do patients with low-grade soft tissue sarcoma die?

    Ann Surg Oncol

    (2008)
  • C.D. Fletcher et al.

    Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group

    Am J Pathol

    (1996)
  • F. Pedeutour et al.

    Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors

    Genes Chromosomes Cancer

    (1999)
  • M. Binh et al.

    MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms

    Am J Surg Pathol

    (2005)
  • C.R. Antonescu et al.

    Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases

    Clin Cancer Res

    (2001)
  • P. Aman et al.

    Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11)

    Genes chromosomes cancer

    (1992)
  • J.C. Knight et al.

    Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis

    Cancer Res

    (1995)
  • T.H. Rabbitts et al.

    Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma

    Nat Genet

    (1993)
  • D. Ron et al.

    CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription

    Genes Dev

    (1992)
  • C.A. Powers et al.

    Is a high-affinity interactor for steroid, thyroid hormone, and retinoid receptors

    Mol Endocrinol

    (1998)
  • M. Kuroda et al.

    Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein

    Am J Pathol

    (1997)
  • F. Mertens et al.

    Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology

    Genes Chromosomes Cancer

    (1998)
  • R. Schneider-Stock et al.

    MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas

    J Cancer Res Clin Oncol

    (1998)
  • K. Engström et al.

    Liposarcoma: outcome based on the Scandinavian Sarcoma Group register

    Cancer

    (2008)
  • S. Singer et al.

    Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma

    Ann Surg

    (2003)
  • J.H. Schwab et al.

    Spinal metastases from myxoid liposarcoma warrant screening with magnetic resonance imaging

    Cancer

    (2007)
  • D. McCormick et al.

    Dedifferentiated liposarcoma: clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas

    Am J Surg Pathol

    (1994)
  • M.D. Murphy et al.

    Imaging of musculoskeletal liposarcoma with radiologic-pathologic correlation

    Radiographics

    (2005)
  • D.C. Linehan et al.

    Influence of biologic factors and anatomic site in completely resected liposarcoma

    J Clin Oncol

    (2000)
  • H.S. Kim et al.

    Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy

    BMC Cancer

    (2009)
  • D.R. Lucas et al.

    Well-differentiated liposarcoma. The Mayo Clinic experience with 58 cases

    Am J Clin Pathol

    (1994)

    • Cited by (0)

    Funding sources: Dr S. Bauer: Deutsche Krebshilfe, Life-Raft-Group, Novartis.

    Conflict of Interest: Dr S. Bauer: Research support: Novartis; Speakers Honoraria: Novartis, Pfizer, Pharmamar, GSK, Bayer. Dr J. Henze: nil.

    View full text
    Copyright © 2013 Elsevier Inc. All rights reserved.